8du8

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "8du8" [edit=sysop:move=sysop])
Current revision (10:14, 25 October 2023) (edit) (undo)
 
(3 intermediate revisions not shown.)
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 8du8 is ON HOLD
+
==Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-((1-propylazetidin-3-yl)oxy)phenyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone==
 +
<StructureSection load='8du8' size='340' side='right'caption='[[8du8]], [[Resolution|resolution]] 1.47&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[8du8]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8DU8 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8DU8 FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.47&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=TS7:[(1R)-6-hydroxy-1-{4-[(1-propylazetidin-3-yl)oxy]phenyl}-1,4-dihydro-2H-spiro[cyclopropane-1,3-isoquinolin]-2-yl](phenyl)methanone'>TS7</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8du8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8du8 OCA], [https://pdbe.org/8du8 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8du8 RCSB], [https://www.ebi.ac.uk/pdbsum/8du8 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8du8 ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/ESR1_HUMAN ESR1_HUMAN] Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full length receptor. Isoform 3 can bind to ERE and inhibit isoform 1.<ref>PMID:7651415</ref> <ref>PMID:10970861</ref> <ref>PMID:9328340</ref> <ref>PMID:10681512</ref> <ref>PMID:10816575</ref> <ref>PMID:11477071</ref> <ref>PMID:11682626</ref> <ref>PMID:15078875</ref> <ref>PMID:16043358</ref> <ref>PMID:15891768</ref> <ref>PMID:16684779</ref> <ref>PMID:18247370</ref> <ref>PMID:17932106</ref> <ref>PMID:19350539</ref> <ref>PMID:20705611</ref> <ref>PMID:21937726</ref> <ref>PMID:21330404</ref> <ref>PMID:22083956</ref>
-
Authors: Hancock, G.R., Young, K.S., Hosfield, D.J., Joiner, C., Sullivan, E.A., Yildz, Y., Laine, M., Greene, G.L., Fanning, S.W.
+
==See Also==
-
 
+
*[[Estrogen receptor 3D structures|Estrogen receptor 3D structures]]
-
Description: Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1''-(4-((1-ethylazetidin-3-yl)oxy)phenyl)-6''-hydroxy-1'',4''-dihydro-2''<i>H</i>-spiro[cyclopropane-1,3''-isoquinolin]-2''-yl)(phenyl)methanone
+
== References ==
-
[[Category: Unreleased Structures]]
+
<references/>
-
[[Category: Laine, M]]
+
__TOC__
-
[[Category: Sullivan, E.A]]
+
</StructureSection>
-
[[Category: Young, K.S]]
+
[[Category: Homo sapiens]]
-
[[Category: Joiner, C]]
+
[[Category: Large Structures]]
-
[[Category: Hosfield, D.J]]
+
[[Category: Fanning SW]]
-
[[Category: Hancock, G.R]]
+
[[Category: Greene GL]]
-
[[Category: Greene, G.L]]
+
[[Category: Hancock GR]]
-
[[Category: Fanning, S.W]]
+
[[Category: Hosfield DJ]]
-
[[Category: Yildz, Y]]
+
[[Category: Joiner C]]
 +
[[Category: Laine M]]
 +
[[Category: Sullivan EA]]
 +
[[Category: Yildz Y]]
 +
[[Category: Young KS]]

Current revision

Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-((1-propylazetidin-3-yl)oxy)phenyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone

PDB ID 8du8

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/8du8"
Personal tools